Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication (Q35064650)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication (English)

1 reference

Europe PubMed Central

6 August 2017

8

object named as

Lex Wunderink

0 references

Richard Bruggeman

object named as

Richard Bruggeman

13

0 references

author name string

Jelle Vehof

1

1 reference

Europe PubMed Central

6 August 2017

Arne J Risselada

2

1 reference

Europe PubMed Central

6 August 2017

Asmar F Y Al Hadithy

3

1 reference

Europe PubMed Central

6 August 2017

Huibert Burger

4

1 reference

Europe PubMed Central

6 August 2017

Harold Snieder

5

1 reference

Europe PubMed Central

6 August 2017

Bob Wilffert

6

1 reference

Europe PubMed Central

6 August 2017

Johan Arends

7

1 reference

Europe PubMed Central

6 August 2017

Henrikus Knegtering

9

1 reference

Europe PubMed Central

6 August 2017

Durk Wiersma

10

1 reference

Europe PubMed Central

6 August 2017

Dan Cohen

11

1 reference

Europe PubMed Central

6 August 2017

Hans Mulder

12

1 reference

Europe PubMed Central

6 August 2017

publication date

19 February 2011

1 reference

Europe PubMed Central

6 August 2017

Psychopharmacology

1 reference

Europe PubMed Central

6 August 2017

216

1 reference

Europe PubMed Central

6 August 2017

2

1 reference

Europe PubMed Central

6 August 2017

257-265

1 reference

Europe PubMed Central

6 August 2017

https://scigraph.springernature.com/pub.10.1007/s00213-011-2211-x

0 references

Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Alternative promoter use and splice variation in the human histamine H1 receptor gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Diabetes and schizophrenia 2005: are we any closer to understanding the link?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Atypical antipsychotics and glucose homeostasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

A comparison of bayesian methods for haplotype reconstruction from population genotype data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

A New Statistical Method for Haplotype Reconstruction from Population Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Novel antipsychotics: comparison of weight gain liabilities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Hypothalamic neuronal histamine modulates adaptive behavior and thermogenesis in response to endogenous pyrogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Blockade of the histamine H1-receptor in the rat ventromedial hypothalamus and feeding elicitation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

8 July 2018

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Weight effects associated with antipsychotics: a comprehensive database analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

27 September 2018

Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

27 September 2018

Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3121946

27 September 2018

The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2211-X

21 January 2018

Metabolic findings from the CATIE trial and their relation to tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/21336576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-011-2211-X

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35064650&oldid=1694409383"